MedPath

Skin changes in patients of Diabetes Mellitus and prediction of long term diabetes induced complications in kidney and eye through examination of vessels over nail fold.

Not Applicable
Conditions
Health Condition 1: null- Diabetes Mellitus cases with cutaneous manifestations
Registration Number
CTRI/2018/03/012719
Lead Sponsor
Ruchi Shah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•All type-II Diabetes Mellitus cases patients attending the Diabetic clinic conducted in O.P.D. 18 ,every Wednesday and daily Medicine (O.P.D.18) and Skin and V.D. O.P.D. having one or more of the following cutaneous manifestations:

Vascular Damage:

-Leg ulceration

-Wet gangrene of the foot

-Erysipelas like erythema

-Diabetic dermopathy

-Rubeosis

Neurological Damage:

-Diabetic foot

-Diabetic foot ulcer

Infections

Obesity and hyperlipidemia related skin disease:

-Acanthosis nigricans

-Skin tags

-Eruptive Xanthomas of the skin

Treatment related Skin manifestations:

-Insulin lipodystrophy

-Allergic reactions to Insulin

-Allergic reactions to oral hypoglycemic drugs

Disease associations and genetic syndromes:

-Reactive perforating collagenosis(Folliculitis)

-Autoimmune disease

-Genetic and other systemic disease

Miscellaneous:

-Granulomatous disorders(Necrobiosis Lipoidica)

-Stiff skin and joints:

Cheiroarthropathy

Finger pebbles

Sceleredema diabeticorum

-Pruritus

-Diabetic Bullae

Exclusion Criteria

•Other dermatologic diseases having relation with Metabolic syndrome like Psoriasis

•Cases having Autoimmune diseases like Systemic Lupus Erythematosus, cleroderma, Systemic Sclerosis which can give rise to abnormal capillaroscopic findings.

•Smoking

•Cases with known liver disease or other multi-system disorders

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢To study the cutaneous manifestations of Diabetes mellitus <br/ ><br>â?¢To demonstrate nailfold capillaroscopy changes due to diabetic microangiopathy <br/ ><br>â?¢To study the correlation between cutaneous and systemic manifestations of Diabetic microangiopathy in terms of Retinopathy and nephropathy <br/ ><br>Timepoint: patients will be assessed at the time of enrollment in the study only.
Secondary Outcome Measures
NameTimeMethod
To study the correlation between cutaneous and systemic manifestations of Diabetic microangiopathy in terms of Retinopathy and nephropathyTimepoint: patients can be followed up every 6 months for new manifestations and ophthalmic checkup
© Copyright 2025. All Rights Reserved by MedPath